Anxiety Disorders and Depression Treatment Market to Reach USD 16.65 Billion by 2032, Growing at 3.53% CAGR | By S&S Insider
Increasing prevalence of anxiety and depression, coupled with innovation in pharmaceutical treatments and growing demand for mental health solutions, fuels growth in the anxiety disorders and ...
FierceBiotech2h
AbbVie makes Richter richer, paying $25M to form discovery pact with Vraylar originator
AbbVie has returned to the source of its antipsychotic powerhouse Vraylar in search of another blockbuster, paying $25 ...
KPBS3h
Anxiety runs deep in Georgia as voters worry about heated rhetoric spurring violence
Voters in the crucial swing state have seen a return of the same kind of extreme rhetoric that dominated discussion in the ...
AbbVie, Gedeon Richter collaborate for discovery, development of novel targets
AbbVie (ABBV) and Gedeon Richter announced a new discovery, co-development and license agreement to advance novel targets for the potential ...
Health on MSN20h
Your Guide To Somatic Symptom Disorder
This condition goes beyond just causing health anxiety. People with SSD excessively focus on any symptoms they may be ...
AbbVie and Gedeon Richter Announce New Collaboration for the Discovery and Development of Novel Targets for Neuropsychiatric Conditions
AbbVie (NYSE: ABBV) and Gedeon Richter Plc. ('Richter') today announced a new discovery, co-development and license agreement to advance novel targets for the potential treatment of neuropsychiatric ...
verywellhealth23h
Anxiety and Crohn’s Disease: What’s the Connection?
Anxiety and depression are more common among people with Crohn’s disease, and they can worsen symptoms. Here’s why and ways ...